Pyoderma gangrenosum associated with active chronic hepatitis: report of two cases
- 1 September 1976
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Dermatology
- Vol. 112 (9) , 1297-1301
- https://doi.org/10.1001/archderm.112.9.1297
Abstract
In 2 patients, active chronic hepatitis was complicated by the development of pyoderma gangrenosum. The favorable response of the pyodermatous lesions to azathioprine therapy suggests that this drug may be of value in treating this disorder in patients for whom corticosteroid therapy produces no benefit or is contraindicated because of side effects. Azathioprine is also a potentially toxic drug and may need to be discontinued. Possible causal relationships between pyoderma gangrenosum and active chronic hepatitis are discussed.This publication has 6 references indexed in Scilit:
- Pyoderma gangrenosum with response to cyclophosphamide therapyThe Journal of Pediatrics, 1967
- Azathioprine therapy of ?autoimmune? diseasesThe American Journal of Medicine, 1966
- Pyoderma GangraenosumJAMA, 1964
- DOSE-RESPONSE RELATIONSHIPS FOR AGENTS INHIBITING IMMUNE RESPONSE1964
- INHIBITION OF LYMPHOCYTE RESPONSE TO INFLAMMATION WITH ANTIMETABOLITES1964
- AUTOANTIBODIES IN HUMAN ULCERATIVE COLITISThe Journal of Experimental Medicine, 1959